Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
CJRB-101
i
Other names:
CJRB-101
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
CJ Biosci
Drug class:
Microbiome modulator
Related drugs:
‹
BMC128 (0)
CBM588 (0)
EDP1503 (0)
GB104 (0)
MaaT013 (0)
MaaT033 (0)
RBX7455 intratumoral (0)
BMC128 (0)
CBM588 (0)
EDP1503 (0)
GB104 (0)
MaaT013 (0)
MaaT033 (0)
RBX7455 intratumoral (0)
›
Associations
News
Trials
Filter by
Latest
11ms
Safety, Tolerability, and Preliminary Efficacy of CJRB-101 With Pembrolizumab in Subjects With Selected Types of Advanced or Metastatic Cancer (clinicaltrials.gov)
P1/2, N=160, Recruiting, CJ Bioscience, Inc. | Not yet recruiting --> Recruiting
11 months ago
Enrollment open • Combination therapy • Metastases
|
BRAF (B-raf proto-oncogene)
|
PD-L1 expression • BRAF mutation • BRAF V600
|
Keytruda (pembrolizumab) • CJRB-101
over1year
Safety, Tolerability, and Preliminary Efficacy of CJRB-101 With Pembrolizumab in Subjects With Selected Types of Advanced or Metastatic Cancer (clinicaltrials.gov)
P1/2, N=160, Not yet recruiting, CJ Bioscience, Inc.
over 1 year ago
New P1/2 trial • Combination therapy • Metastases
|
BRAF (B-raf proto-oncogene)
|
PD-L1 expression • BRAF mutation • BRAF V600
|
Keytruda (pembrolizumab) • CJRB-101
Share via
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login